2026 NPPES data Ophthalmology Physician NPI 1053389643 M.D.
Verify on CMS →

MARK FREEDMAN, M.D.

Ophthalmology Physician in WEST ALLIS, Wisconsin. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
161
Medicare Part D claims · 82 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
52%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
92.7547/100
▲ 10 pts above national avg 83.1 · [object Object]

What the federal data shows

MARK FREEDMAN, M.D. reported a CMS MIPS final score of 92.7547/100 — above the 83.1 national average — and filed 161 Medicare Part D claims in 2023.

92.7547/100
MIPS score · +10 vs avg
161
Part D claims, 2023
52%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK FREEDMAN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

93 Top 32% higher than 68% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK FREEDMAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK FREEDMAN, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 03/09/2006

NPI 1053389643

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

161 89% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

92.7547/100 9.654700000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Wisconsin

How Ophthalmology Physician compares to other specialties among Wisconsin providers

Wisconsin providers

Ophthalmology Physician share within Wisconsin

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Wisconsin

Medicare quality performance — MIPS

MARK FREEDMAN, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average

High performer (top quartile)
MIPS Final Score
92.7547/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 92.7547/100 vs national avg 83.1

0%100%National avg83%92.8%
MIPS final score (Ophthalmology Physician) — 92.7547/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK FREEDMAN, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 10150 W NATIONAL AVE, WEST ALLIS, WI, 53227, with a listed phone of (414) 321-7520. NPI 1053389643 was issued on 03/09/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FREEDMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 161 prescription claims written by this provider, covering 82 Medicare beneficiaries and totaling roughly $33K in drug spend, split 48% brand-name and 52% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 92.7547/100 for the 2023 performance year (Quality 100, Cost 75.849), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10150 W NATIONAL AVE
WEST ALLIS, WI 53227

Provider Details

NPI 1053389643
Specialty Ophthalmology Physician
Credentials M.D.
Gender Male
NPI Issued 03/09/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

92.7547
Final Score
Avg: 83.1
100
Quality
75.849
Cost

Reporting: Group practice

Brand vs generic prescribing mix · Above average

MARK FREEDMAN, M.D. — brand share 48.0%
Specialty average (est.)

48% brand-name claims vs 52% generic, on 161 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

161
Total Claims
$33K
Total Drug Cost
82
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
335
Total Day Supply
9,814
Brand vs Generic
48% brand / 52% generic
Brand Drug Cost
$26K
Generic Drug Cost
$6K

Patient Demographics

Average Patient Age
79.7 years
Avg HCC Risk Score
1.23
Gender Split
62% female / 38% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK FREEDMAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
74
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
18
Lumigan
Bimatoprost
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How MARK FREEDMAN, M.D. fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

MARK FREEDMAN, M.D.'s 161 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Wisconsin

Other clinicians with the same primary specialty enrolled in Wisconsin, drawn from the same CMS NPPES roster as FREEDMAN.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK FREEDMAN, M.D.'s specialty?
MARK FREEDMAN, M.D. specializes in Ophthalmology Physician and practices in WEST ALLIS, Wisconsin. Credentials: M.D..
How much does MARK FREEDMAN, M.D. prescribe under Medicare Part D?
In 2023, MARK FREEDMAN, M.D. wrote 161 Medicare Part D claims totaling $33K in drug costs for 82 beneficiaries.
What is MARK FREEDMAN, M.D.'s Medicare quality score?
MARK FREEDMAN, M.D. has a CMS MIPS Final Score of 92.7547/100 (Quality: 100, Cost: 75.849). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK FREEDMAN, M.D. located?
MARK FREEDMAN, M.D. is located at 10150 W NATIONAL AVE, WEST ALLIS, WI, 53227. Phone: (414) 321-7520.
What is MARK FREEDMAN, M.D.'s NPI number?
MARK FREEDMAN, M.D.'s National Provider Identifier (NPI) is 1053389643, issued on 03/09/2006.
Does MARK FREEDMAN, M.D. prescribe more brand-name or generic drugs?
MARK FREEDMAN, M.D.'s prescribing is 48% brand-name and 52% generic drugs by claim count, with $26K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does MARK FREEDMAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK FREEDMAN, M.D.'s most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Lumigan. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK FREEDMAN, M.D. accept Medicare?
MARK FREEDMAN, M.D. appears in CMS Medicare data with 161 Part D claims and 82 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK FREEDMAN, M.D.'s credentials?
MARK FREEDMAN, M.D.'s NPI is 1053389643 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology